4 completed. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow oltipraz: new trials by email Literature Review of oltipraz trials Research Report on oltipraz
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis Oltipraz, Placebos - Non-Alcoholic Fatty Liver Disease | Phase 3 | Completed | PharmaKing | 146 | 2019-11-15 | 2022-10-06 |
| Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease Placebo, Oltipraz - Non-alcoholic Fatty Liver Disease | Phase 2 | Completed | PharmaKing | 60 | 2011-05-01 | 2013-12-10 |
| Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis oltipraz, placebo - Liver Fibrosis, Liver Cirrhosis | Phase 2 | Completed | HK inno.N Corporation | 81 | 2006-02-01 | 2009-08-11 |
| Oltipraz in the Prevention of Lung Cancer in People Who Smoke oltipraz - Lung Cancer | Phase 1 | Completed | Northwestern University | 2000-08-01 | 2012-06-11 |
Non-alcoholic Fatty Liver Disease (2) · Carcinoma, Non-Small-Cell Lung (1) · Liver Cirrhosis (1) · Lung Neoplasms (1) · Small Cell Lung Carcinoma (1)
PharmaKing (2) · HK inno.N Corporation (1) · Northwestern University (1)
South Korea (3) · United States (1)
Byeongguk Jang, MD.PhD (1) · Byeonggwan Kim, MD.PhD (1) · Changuk Kim, MD.PhD (1) · Chun Kyun Lee, MD.PhD (1) · Daewon Jun, MD.PhD (1) · Doyeong Kim, MD.PhD (1) · Gapjin Chun, MD.PhD (1) · Huieon Kim, MD.PhD (1) · Hyeongjun Kim, MD.PhD (1) · Hyeonung Lee, MD.PhD (1) · Jaeyeong Chang, MD.PhD (1) · Jaeyeong Jung, MD.PhD (1) · Jaeyun Jung, MD.PhD (1) · Jihun Kim, MD.PhD (1) · Jinu Lee, MD.PhD (1)